Usefulness of Measuring Thyroid Stimulating Antibody at the Time of Antithyroid Drug Withdrawal for Predicting Relapse of Graves Disease.

Hyemi KwonWon Gu KimEun Kyung JangMijin KimSuyeon ParkMin Ji JeonTae Yong KimJin Sook RyuYoung Kee ShongWon Bae Kim

Published in: Endocrinology and metabolism (Seoul, Korea) (2016)

TSAb at ATD withdrawal can predict the relapse of Graves hyperthyroidism, but TBII cannot. Measuring TSAb at ATD withdrawal can assist with clinical decisions making for patients with Graves disease.

Keyphrases

free survival
adverse drug